Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Provided By PR Newswire
Last update: Jan 31, 2024
MARLBOROUGH, Mass., Jan. 31, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a reported basis, 14.5 percent on an operational1 basis and 13.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $504 million or $0.34 per share (EPS), compared to $126 million or $0.09 per share a year ago and achieved adjusted3 EPS of $0.55 for the period, compared to $0.45 a year ago.
Read more at prnewswire.com104.32
+0.69 (+0.67%)
Find more stocks in the Stock Screener
BSX Latest News and Analysis
8 days ago - ChartmillBOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Contender in Growth and MomentumBoston Scientific Corp (NYSE:BSX) shows strong technical and fundamental growth, fitting Minervini’s trend template with high earnings momentum and improving margins. A top pick for momentum investors.
12 days ago - ChartmillBOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical SetupBoston Scientific Corp (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid support levels and consolidation patterns ahead of a potential breakout.
